2Yvan J, Mathieu GV, Fabio M, et al. Pathogenesis of adult-onset Stillsdisease:new insights from the juvenile counterpart [J] .ImmunologicResearch, 2015, 61(1-2) : 53-62.
3Kadavath S, Efthimiou P. Adult-onset Still’s disease-pathogenesis,clinical manifestations, and new treatment options [j]. Ann Med, 2015,47(1): 1-9.
4Nakamura H, Odani T, Shimizu Y, et al. Usefulness of tacrolimusfor refractory adult-onset stills disease: Report of six cases[j] .ModRheumatol} 2014,18(1) :1-5.
5Gerfaud VM, Jamilloux Y, Iwaz J, et al. Adult-onset Still's disease[J].Autoimmun Rev, 2014,13(7):708-722.
6Paola C, Piero R, Francesco C, et al. Tocilizumab for the treatmentof adult-onset Stills disease: results from a case series [J]. ClinicalRheumatology 2014, 33(1): 49-55.
